SCHEMBL122704

SCHEMBL122704

Cc1n[nH]cc1C(c1ccccc1)N1CCN(c2cccnc2Cl)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 4/20 0.41
POLB P06746 2/20 0.41
EGFR P00533 1/20 0.39
MEN1 O00255 3/20 0.38
MAPK1 P28482 3/20 0.38
KMT2A Q03164 3/20 0.38
TSHR P16473 3/20 0.38
LMNA P02545 2/20 0.38
TP53 P04637 2/20 0.38
ALOX15 P16050 2/20 0.38
USP2 O75604 1/20 0.38
HSD17B10 Q99714 1/20 0.38
GAA P10253 1/20 0.37
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPY2R P49146 1/20 0.36
MAPT P10636 3/20 0.36
TDP1 Q9NUW8 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL124436 0.86 NPSR1 (0.41) NPSR1KDM4EALDH1A1POLBEGFR
SCHEMBL125414 0.81 ALDH1A1 (0.51) NPSR1KDM4EALDH1A1POLBEGFR
Hydrochloric Acid SCHEMBL121959 0.79 LRRK2 (0.39) NPSR1MEN1MAPK1KMT2ATP53
Hydrochloric Acid SCHEMBL123212 0.74 MAPK1 (0.39) NPSR1KDM4EALDH1A1EGFRMEN1
SCHEMBL3322684 0.73 MEN1 (0.38) NPSR1KDM4EALDH1A1EGFRMEN1
Hydrochloric Acid SCHEMBL3321180 0.73 RPS6KB1 (0.43) NPSR1ALDH1A1MEN1MAPK1KMT2A
Hydrochloric Acid SCHEMBL125247 0.72 LRRK2 (0.42) ACHE
SCHEMBL3319668 0.72 MEN1 (0.38) NPSR1KDM4EALDH1A1POLBMEN1
Hydrochloric Acid SCHEMBL3320444 0.71 MEN1 (0.38) NPSR1KDM4EALDH1A1MEN1MAPK1
SCHEMBL3325588 0.71 MAPT (0.36) NPSR1ALDH1A1MEN1MAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155717-B1 2-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-3-PHENYL PYRAZINES AND PYRIDINES AND 3-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-2-PHENYL PYRIDINES AS 5-HT7 RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2012-10-24 EP disclosed
US-8202873-B2 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor antagonists ELI LILLY AND COMPANY (US) 2012-06-19 US disclosed
EP-2201002-B1 5-HT7 RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2012-03-07 EP disclosed
US-7910588-B2 5-HT7 receptor antagonists ELI LILLY AND COMPANY (US) 2011-03-22 US disclosed
US-20100197700-A1 5-HT7 RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY 2010-08-05 US disclosed
US-20100120785-A1 2-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-3-PHENYL PYRAZINES AND PYRIDINES AND 3-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-2-PHENYL PYRIDINES AS 5-HT7 RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197700-A1 5-HT7 RECEPTOR ANTAGONISTS HTR7, HTR1A, HTR2C NPSR1 37/4885KDM4E 2286/4885ALDH1A1 2150/4885
US-20100120785-A1 2-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-3-PHENYL PYRAZINES AND PYRIDINES AND 3-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-2-PHENYL PYRIDINES AS 5-HT7 RECEPTOR ANTAGONISTS HTR7, HTR2C, HTR4 NPSR1 59/4885KDM4E 1816/4885ALDH1A1 1205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.